| Submission of formal petitions and representations to PMDA [Pharmaceuticals and Medical Devices Agency] and the MHLW [Mōrōshō – Ministry of Health, Labour and Welfare]. | 病患倡導
> 病患倡導 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 100 | National | Sometimes | 119036459439 |
| Towards the approval of molecularly targeted therapies. | 巨蟹座
> 癌症：肺 | 監管合作關係
> 貢獻至行銷授權申請 | 1,000 | Regional | Rarely | 119053044699 |
| We submit a formal petition to the [Japanese] Ministry of Health, Labour and Welfare (MHLW) once a year and conduct a follow-up meeting. | 移植
> 移植：最多 | 監管合作關係
> 出席/主持與政策制定者/監管機構的會議 | 100 | National | Regularly | 119051955551 |
| I participate in petition campaigns through the National Psoriasis Patients Federation. | 皮膚
> 乾癬 | 監管合作關係
> 與其他醫療倡導者 | 100 | Regional | Rarely | 119013683256 |
| Every year, we submit budget requests for the following fiscal year to the national government and prefectural governments. | 肝臟
> 肝臟疾病：大多數類型 | 影響政策與立法
> 影響醫療保健政策與法規 | 5,000 | National | Regularly | 119036457777 |
| We have organised vaccine awareness marches and submitted formal written requests to the Kōrōshō [厚生労働省 – Ministry of Health, Labour and Welfare]. | 傳染性
> 傳染病：其他 | 影響政策與立法
> 參與公開聽證會及諮詢 | 100 | National | Sometimes | 119035140720 |
| We submit a formal written petition to the MHLW [Mōsō Rōdōshō – Ministry of Health, Labour and Welfare] once a year. | 移植
> 移植：最多 | 影響政策與立法
> 參與公開聽證會及諮詢 | 100 | National | Regularly | 119051955551 |
| Once a year, the organisation submits its formal requests at the opinion exchange forum held jointly with the prefectural and municipal authorities. | 風濕性
> 風濕性疾病：其他 | 影響政策與立法
> 參與公開聽證會及諮詢 | 100 | National | Regularly | 119078001121 |
| Visited the House of Representatives members' office building and held a meeting with a member of parliament. | 風濕性
> 風濕性疾病：大多數類型 | 影響政策與立法
> 動員國會議員與政治領袖 | 1,000 | National | Rarely | 119014930939 |
| Submission of a written petition to the Minister of Health, Labour and Welfare. | 內分泌
> 糖尿病：第1型 | 影響政策與立法
> 動員國會議員與政治領袖 | 100,000 | National | Regularly | 119019815441 |
| Expedited approval of stem cell-based regenerative medicine products. | 稀有
> 罕見疾病：EB | 影響政策與立法
> 解決醫療照護中的障礙/異常問題 | 1,000 | National | Sometimes | 119077906981 |
| Early approval of new medicines, resolution of drug lag and drug loss, and applications based on established medical knowledge. | 巨蟹座
> 癌症：胰臟癌 | 影響政策與立法
> 解決醫療照護中的障礙/異常問題 | 10,000 | National | Regularly | 119079604807 |
| Insurance reimbursement coverage for Pegasys [peginterferon alfa-2a, used to treat chronic hepatitis B and C, as well as rare cancers]. | 巨蟹座
> 癌症：血液 | 定價與可負擔性倡議
> 倡導將產品納入給付清單/國家藥品目錄 | 1,000 | National | Regularly | 119014697897 |
| We have organised vaccine awareness marches and submitted formal written requests to the Kōrōshō [厚生労働省 – Ministry of Health, Labour and Welfare]. | 傳染性
> 傳染病：其他 | 定價與可負擔性倡議
> 參與宣傳活動 | 100 | National | Sometimes | 119035140720 |
| A request for greater disease awareness. | 未指定
> 未指定 | 定價與可負擔性倡議
> 參與宣傳活動 | 100 | National | Regularly | 119061457501 |
| Towards the approval of molecularly targeted therapies [for lung cancer]. | 巨蟹座
> 癌症：肺 | 改善存取路徑
> 促進藥品/醫療保健的公平取得 | 1,000 | Regional | Rarely | 119053044699 |
| Key advocacy priorities include: accelerated approval pathways for new medicines, resolution of drug lag and drug loss issues, and the known-use application process (applications for medicines already recognised in the scientific literature or approved in other jurisdictions). | 巨蟹座
> 癌症：胰臟癌 | 改善存取路徑
> 促進藥品/醫療保健的公平取得 | 10,000 | National | Regularly | 119079604807 |
| We have organised vaccine awareness marches and submitted formal written requests to the Kōrōshō [厚生労働省 – Ministry of Health, Labour and Welfare]. | 傳染性
> 傳染病：其他 | 改善存取路徑
> 倡導更廣泛的疫苗取得管道 | 100 | National | Sometimes | 119035140720 |
| Insurance reimbursement coverage for Pegasys [peginterferon alfa-2a, used to treat chronic hepatitis B and C, as well as rare cancers]. | 巨蟹座
> 癌症：血液 | 改善存取路徑
> 改善罕見/極罕見療法的取得管道 | 1,000 | National | Regularly | 119014697897 |
| Expedited approval of stem cell-based regenerative medicine products. | 稀有
> 罕見疾病：EB | 改善存取路徑
> 改善罕見/極罕見療法的取得管道 | 1,000 | National | Sometimes | 119077906981 |
| The Ministry of Health, Labour and Welfare; the Medical Insurance Subcommittee of the Social Security Council; and related bodies. | 過敏
> 過敏 | 機構治理
> 確保在政府諮詢機構中獲得代表性 | 100,000 | National | Sometimes | 119078144899 |
互動
行動與倡議
4 提及
